Drugs giant admits control failings

Drugs giant GlaxoSmithKline has admitted that certain top executives appeared to have broken the law, as the company faces an investigation over multi-million bribery allegations in China.

The company also said it would cut medicine prices for Chinese patients in the wake of the scandal, in which funds were alleged to have been paid to doctors and health officials to boost sales and raise prices.%VIRTUAL-SkimlinksPromo%